Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled unfractionated heparin for mild to moderate COVID-19
MOH_2021-03-11_009525Phase 2Not yet recruiting
- Sponsor
- פרופ' יונה נדיר
- Start
- Nov 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Inhaled unfractionated heparin with Inhaled placebo saline (2 arms). Planned start Nov 2020; status: not yet recruiting.
02
Drugs
heparin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on MOH_2021-03-11_009525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-03-11_009525.